Real-time seroprevalence and exposure levels of emerging pathogens in infection-naive host populations

Francesco Pinotti, Uri Obolski, Paul Wikramaratna, Marta Giovanetti, Robert Paton, Paul Klenerman, Craig Thompson, Sunetra Gupta, José Lourenço*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


For endemic pathogens, seroprevalence mimics overall exposure and is minimally influenced by the time that recent infections take to seroconvert. Simulating spatially-explicit and stochastic outbreaks, we set out to explore how, for emerging pathogens, the mix of exponential growth in infection events and a constant rate for seroconversion events could lead to real-time significant differences in the total numbers of exposed versus seropositive. We find that real-time seroprevalence of an emerging pathogen can underestimate exposure depending on measurement time, epidemic doubling time, duration and natural variation in the time to seroconversion among hosts. We formalise mathematically how underestimation increases non-linearly as the host’s time to seroconversion is ever longer than the pathogen’s doubling time, and how more variable time to seroconversion among hosts results in lower underestimation. In practice, assuming that real-time seroprevalence reflects the true exposure to emerging pathogens risks overestimating measures of public health importance (e.g. infection fatality ratio) as well as the epidemic size of future waves. These results contribute to a better understanding and interpretation of real-time serological data collected during the emergence of pathogens in infection-naive host populations.

Original languageEnglish
Article number5825
JournalScientific Reports
Issue number1
Publication statusPublished - Dec 2021
Externally publishedYes


Dive into the research topics of 'Real-time seroprevalence and exposure levels of emerging pathogens in infection-naive host populations'. Together they form a unique fingerprint.

Cite this